109 related articles for article (PubMed ID: 26935885)
1. Reversal of liver cancer-associated stellate cell-induced stem-like characteristics in SMMC-7721 cells by 8-bromo-7-methoxychrysin via inhibiting STAT3 activation.
Cui Y; Sun S; Ren K; Quan M; Song Z; Zou H; Li D; Cao J
Oncol Rep; 2016 May; 35(5):2952-62. PubMed ID: 26935885
[TBL] [Abstract][Full Text] [Related]
2. 8-bromo-7-methoxychrysin suppress stemness of SMMC-7721 cells induced by co-culture of liver cancer stem-like cells with hepatic stellate cells.
Wen Q; Xu C; Zhou J; Liu NM; Cui YH; Quan MF; Cao JG; Ren KQ
BMC Cancer; 2019 Mar; 19(1):224. PubMed ID: 30866863
[TBL] [Abstract][Full Text] [Related]
3. 8-Bromo-7-methoxychrysin-blocked STAT3/Twist axis inhibits the stemness of cancer stem cell-like cell originated from SMMC-7721 cells.
Luo Y; Cui Y; Cao X; Li X; Chen A; Zhang J; Chen X; Cao J
Acta Biochim Biophys Sin (Shanghai); 2017 May; 49(5):458-464. PubMed ID: 28369327
[TBL] [Abstract][Full Text] [Related]
4. Synergistic inhibition of characteristics of liver cancer stem-like cells with a combination of sorafenib and 8-bromo-7-methoxychrysin in SMMC-7721 cell line.
Zou H; Cao X; Xiao Q; Sheng X; Ren K; Quan M; Song Z; Li D; Zheng Y; Zeng W; Cao J; Peng Y
Oncol Rep; 2016 Sep; 36(3):1731-8. PubMed ID: 27461522
[TBL] [Abstract][Full Text] [Related]
5. 8-bromo-7-methoxychrysin Reversed M2 Polarization of Tumor-associated Macrophages Induced by Liver Cancer Stem-like Cells.
Sun S; Cui Y; Ren K; Quan M; Song Z; Zou H; Li D; Zheng Y; Cao J
Anticancer Agents Med Chem; 2017; 17(2):286-293. PubMed ID: 26845136
[TBL] [Abstract][Full Text] [Related]
6. Disruption of crosstalk between LX-2 and liver cancer stem-like cells from MHCC97H cells by DFOG via inhibiting FOXM1.
Chen A; Xu C; Luo Y; Liu L; Song K; Deng G; Yang M; Cao J; Yuan L; Li X
Acta Biochim Biophys Sin (Shanghai); 2019 Dec; 51(12):1267-1275. PubMed ID: 31750892
[TBL] [Abstract][Full Text] [Related]
7. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.
Quan MF; Xiao LH; Liu ZH; Guo H; Ren KQ; Liu F; Cao JG; Deng XY
World J Gastroenterol; 2013; 19(43):7680-95. PubMed ID: 24431896
[TBL] [Abstract][Full Text] [Related]
8. 8-bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of Twist signaling.
Ren KQ; Cao XZ; Liu ZH; Guo H; Quan MF; Liu F; Jiang L; Xiang HL; Deng XY; Cao JG
Int J Oncol; 2013 Nov; 43(5):1719-29. PubMed ID: 23970349
[TBL] [Abstract][Full Text] [Related]
9. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo.
Mußbach F; Ungefroren H; Günther B; Katenkamp K; Henklein P; Westermann M; Settmacher U; Lenk L; Sebens S; Müller JP; Böhmer FD; Kaufmann R
Mol Cancer; 2016 Jul; 15(1):54. PubMed ID: 27473374
[TBL] [Abstract][Full Text] [Related]
10. Hepatic stellate cells secreted hepatocyte growth factor contributes to the chemoresistance of hepatocellular carcinoma.
Yu G; Jing Y; Kou X; Ye F; Gao L; Fan Q; Yang Y; Zhao Q; Li R; Wu M; Wei L
PLoS One; 2013; 8(9):e73312. PubMed ID: 24023859
[TBL] [Abstract][Full Text] [Related]
11. The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma.
Chen JJ; Cai N; Chen GZ; Jia CC; Qiu DB; Du C; Liu W; Yang Y; Long ZJ; Zhang Q
Oncotarget; 2017 Mar; 8(11):17593-17609. PubMed ID: 26061710
[TBL] [Abstract][Full Text] [Related]
12. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
13. A candidate Chinese medicine preparation-Fructus Viticis Total Flavonoids inhibits stem-like characteristics of lung cancer stem-like cells.
Cao X; Zou H; Cao J; Cui Y; Sun S; Ren K; Song Z; Li D; Quan M
BMC Complement Altern Med; 2016 Sep; 16():364. PubMed ID: 27633248
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
15. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of hepatic stellate cells against cisplatin-induced apoptosis in human hepatoma G2 cells.
Zhang L; Li Y; Qiao L; Zhao Y; Wei Y; Li Y
Int J Oncol; 2015 Aug; 47(2):632-40. PubMed ID: 26035065
[TBL] [Abstract][Full Text] [Related]
17. STAT3 activation mediates epithelial-to-mesenchymal transition in human hepatocellular carcinoma cells.
Zhang CH; Guo FL; Xu GL; Jia WD; Ge YS
Hepatogastroenterology; 2014 Jun; 61(132):1082-9. PubMed ID: 26158169
[TBL] [Abstract][Full Text] [Related]
18. NSC 74859 enhances doxorubicin cytotoxicity via inhibition of epithelial-mesenchymal transition in hepatocellular carcinoma cells.
Hu QD; Chen W; Yan TL; Ma T; Chen CL; Liang C; Zhang Q; Xia XF; Liu H; Zhi X; Zheng XX; Bai XL; Yu XZ; Liang TB
Cancer Lett; 2012 Dec; 325(2):207-13. PubMed ID: 22781398
[TBL] [Abstract][Full Text] [Related]
19. Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1-Stat3.
Wu CX; Xu A; Zhang CC; Olson P; Chen L; Lee TK; Cheung TT; Lo CM; Wang XQ
Mol Cancer Ther; 2017 Aug; 16(8):1531-1543. PubMed ID: 28522590
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Stellate Cells Contribute to the Tumor Malignancy of Hepatocellular Carcinoma Through the IL-6 Pathway.
Iwahasi S; Rui F; Morine Y; Yamada S; Saito YU; Ikemoto T; Imura S; Shimada M
Anticancer Res; 2020 Feb; 40(2):743-749. PubMed ID: 32014916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]